Barnes TL, MacLeod S, Tkatch R, Ahuja M, Albright L, Schaeffer JA, Yeh CS. Cumulative effect of loneliness and social isolation on health outcomes among older adults. Aging Ment Health. 2022 Jul;26(7):1327-34. doi: 10.1080/13607863.2021.1940096
Tkatch R, Wu L, MacLeod S, Ungar R, Albright L, Russell D, Murphy J, Schaeffer J, Yeh CS. Reducing loneliness and improving well-being among older adults with animatronic pets. Aging Ment Health. 2021 Jul;25(7):1239-45. doi: 10.1080/13607863.2020.1758906
Bell TR, Hill NL, Bhargava S, Mogle J. Parental dementia and subjective memory impairment in the health and retirement study. Aging Ment Health. 2021 May;26(5):992-1000. doi: 10.1080/13607863.2021.1910790
Bhang I, Mogle J, Hill N, Whitaker EB, Bhargava S. Examining the temporal associations between self-reported memory problems and depressive symptoms in older adults. Aging Ment Health. 2020 Nov;24(11):1864-71. doi: 10.1080/13607863.2019.1647135
Mansfield C, Sutphin J, Boeri M. Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question. Health Econ. 2020 Oct;29(10):1307-15. doi: 10.1002/hec.4124
Mogle J, Hill N, Bhang I, Bhargava S, Whitaker E, Kitt-Lewis E. Time frame, problem specificity, and framing: the implicit structures of questions about memory in older adults. Aging Ment Health. 2020 Jan;24(1):56-62. doi: 10.1080/13607863.2018.1523882
Heidenreich S, Watson V, Ryan M, Phimister E. Decision heuristic or preference? Attribute non-attendance in discrete choice problems. Health Econ. 2018 Jan;27(1):157-71. doi: 10.1002/hec.3524
Tsuchiya A, Watson V. Re-thinking “the different perspectives that can be used when eliciting preferences in health". Health Econ. 2017 Dec;26(12):e103-7. doi: 10.1002/hec.3480
Krucien N, Watson V, Ryan M. Is best-worst scaling suitable for health state valuation? A comparison with discrete choice experiments. Health Econ. 2017 Dec;26(12):e1-e16. doi: 10.1002/hec.3459
Watson V, Becker F, de Bekker-Grob E. Discrete choice experiment response rates: a meta-analysis. Health Econ. 2017 Jun;26(6):810-7. doi: 10.1002/hec.3354
Shakoor A, Esterberg E, Acharya NR. Recurrence of uveitis after discontinuation of infliximab. Ocul Immunol Inflamm. 2014 Apr;22(2):96-101. doi: 10.3109/09273948.2013.812222
Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Houser KA, Keyes V. Benefits and costs of substance abuse treatment programs for state prison inmates: results from a lifetime simulation model. Health Econ. 2012 Jun;21(6):633-52.
Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012 Feb;20(1):18-26. doi: 10.3109/09273948.2011.633205.
Ryan M, Watson V. Comparing welfare estimates from payment card contingent valuation and discrete choice experiments. Health Econ. 2009 Apr;18(4):389-401. doi: 10.1002/hec.1364
Ryan M, Watson V, Entwistle V. Rationalising the 'irrational': a think aloud study of discrete choice experiment responses. Health Econ. 2009 Mar;18(3):321-36. doi: 10.1002/hec.1369
Doward L, Karim S, Ramanna G, Petit T, Burns A. Development of the Dementia Quality of Life questionnaire (D-QOL): uK version. Aging Ment Health. 2008 Jan;12(1):144-8.
Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.